MedPath

A study to see effect of yoga in the treatment of nonalcoholic fatty liver disease

Phase 2
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2023/10/059300
Lead Sponsor
All India Institute of Medical Sciences Bhopal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participant having age between 18-60 years of age

2. Participant diagnosed as case of NAFLD (CAP score = 238 dB/m on VCTE)

3. Participants who gives consent

Exclusion Criteria

: 1. Patients with overt cirrhosis (Patients with gross ascites and hepatic encephalopathy)

2. Patients with positive Hepatitis B surface antigen

3. Patients with positive antibody against hepatitis C virus

4. Patients with congestive hepatopathy (Patients with tender hepatomegaly, elevated JVP, right heart failure on 2D Echo)

5. Pregnant females

6. Patients with active malignancy

7. Patients with secondary causes of fatty liver (eg, consumption of amiodarone and tamoxifen)

8. Patients using /have used hepatotoxic drugs in the last 6 months (over 4 g/day of acetaminophen, methotrexate, nitrofurantoin, and rifampicin).

9. Men who consumed >140g and women who consumed >70 g of alcohol per week for at least 10 years were also excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath